Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

E M Carvalho; R Badaró; S G Reed; T C Jones; W D Johnson

doi:10.1172/JCI112209

Find articles by Carvalho, E. in: JCI | PubMed | Google Scholar

Find articles by Badaró, R. in: JCI | PubMed | Google Scholar

Find articles by Reed, S. in: JCI | PubMed | Google Scholar

Find articles by Jones, T. in: JCI | PubMed | Google Scholar

Find articles by Johnson, W. in: JCI | PubMed | Google Scholar

Published in Volume 76, Issue 6 on December 1, 1985
J Clin Invest. 1985;76(6):2066–2069. https://doi.org/10.1172/JCI112209.
© 1985 The American Society for Clinical Investigation

Published December 1, 1985 - Version history

The lymphocytes from eight patients with active visceral leishmaniasis (VL), a disease associated with marked immunologic dysfunction, were examined for ability to produce interleukin 2 (IL-2) and gamma interferon during in vitro cultivation. It was found that both IL-2 and gamma interferon production, in response to leishmania antigen, was absent during the active disease, but was restored after successful chemotherapy. Untreated VL patients produced IL-2 and gamma interferon when stimulated with phytohemagglutinin (PHA). Six patients with either active cutaneous or mucosal leishmaniasis, a disease not associated with immunosuppression, showed high levels of gamma interferon in response to leishmania antigen and PHA. Since IL-2 and gamma interferon have been shown to have important roles in the immune response and in the killing of leishmania, their absence may represent a key defect in the immune response in VL.

Click on an image below to see the page. View PDF of the complete article